2ND INTERNATIONAL SYMPOSIUM ON FUNCTIONAL GI DISORDERS

描述(取自应用程序) 国际肠道功能障碍基金会(IFBD)是一家非营利性组织 解决与生活有关的问题的教育组织 功能性肠病和大便失禁。IFBD提供支持和 对受影响的人、他们的家人和普通公众进行教育。 作为其使命的一部分，IFBD促进与肠道疾病相关的研究 并为医疗保健提供者和研究人员赞助教育项目。 IFBD咨询委员会由医生、护士、职业人员组成 治疗师、心理学家、医学研究人员和医学院 教授，他们与总统密切合作，计划和实施 教育方案，如拟议的第二届国际研讨会 功能性胃肠道疾病。1997年专题讨论会的目标是提供国家 关于功能性胃肠道疾病的ART信息和 推动加大诊疗临床研究力度。这个 研讨会鼓励采用生物、心理和社会方法进行研究和治疗 这些疾病，包括检查相互关联的生物学， 心理和社会因素。 活动将包括大小组学习机会和小小组学习机会。 大型小组全体会议将提供基础科学的概述 和与功能性胃肠道疾病相关的生理学，相关的医疗保健 成本和最先进的诊断方法。全体会议还将 对生物-心理-社会入路及药理学和 肠胃的心理治疗。小组会议将是参与性的 在性质上允许演讲者和与会者之间的专业交流。 11个主题将分成小组讨论，包括食道和 胃十二指肠运动，小肠/胃十二指肠，结肠运动， 肛门直肠动力、内脏敏感性、面谈技巧和 沟通技能、诊断方法、心理测试和 评估、心理治疗、肠道药理学和 精神药理学。

DESCRIPTION (Taken from application) The International Foundation for Bowel Dysfunction (IFBD) is a nonprofit education organization which addresses issues surrounding life with functional bowel disorders and bowel incontinence. IFBD offers support and education to affected people, their families, and the general public. As part of its mission, IFBD promotes research related to bowel disorders and sponsors educational programs for health care providers and researchers. IFBD's Advisory Board consists of physicians, nurses, occupational therapists, psychologists, medical researchers, and medical school professors, who work closely with the President to plan and implement educational programs such as the proposed 2nd International Symposium on Functional GI Disorders. The goal of the 1997 Symposium is to provide state of the art information on functional gastrointestinal disorders and to promote increased clinical research on diagnosis and treatment. The Symposium encourages a biopsychosocial approach to the study and treatment of these disorders, which includes examination of inter-related biological, psychological, and social factors. The event will include both large and small group learning opportunities. Large group plenary sessions will provide an overview of the basic science and physiology related to functional GI disorders, related health care costs, and state of the art diagnostic methods. Plenary sessions will also offer discussion of the biopsychosocial approach and the pharmacologic and psychologic treatment of the Gut. Small group sessions will be participatory in nature to allow for professional exchange between speakers and attendees. Eleven topics will be addressed in small groups, including esophageal and gastroduodenal motility, small bowel/gastroduodenal, colonic motility, anorectal motility, visceral sensitivity, interview techniques and communication skills, diagnostic approach, psychologic testing and assessment, psychologic treatments, gut pharmacology, and psychopharmacology.